This paper is in the following e-collection/theme issue:

Methods and Feasibility Studies (380)

Published on in Vol 5, No 2 (2016): Apr-Jun

Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure: Results from the CARRYING ON for HF Pilot Study

Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure: Results from the CARRYING ON for HF Pilot Study

Cardiac Rhythm Monitoring After Acute Decompensation for Heart Failure: Results from the CARRYING ON for HF Pilot Study

Authors of this article:

Emilio Vanoli1 Author Orcid Image ;   Andrea Mortara2 Author Orcid Image ;   Paolo Diotallevi3 Author Orcid Image ;   Giuseppe Gallone2 Author Orcid Image ;   Barbara Mariconti4 Author Orcid Image ;   Edoardo Gronda5 Author Orcid Image ;   Alessandra Gentili6 Author Orcid Image ;   Silvia Bisetti7 Author Orcid Image ;   Giovanni Luca Botto4 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Journals

  1. LACOUR P, DANG P, HUEMER M, PARWANI A, ATTANASIO P, PIESKE B, BOLDT L, HAVERKAMP W, BLASCHKE F. Performance of the New BioMonitor 2‐AF Insertable Cardiac Monitoring System: Can Better be Worse?. Pacing and Clinical Electrophysiology 2017;40(5):516 View
  2. Reinsch N, Ruprecht U, Buchholz J, Diehl R, Kälsch H, Neven K. The BioMonitor 2 insertable cardiac monitor: Clinical experience with a novel implantable cardiac monitor. Journal of Electrocardiology 2018;51(5):751 View
  3. Gue Y, Correa E, Thompson J, Homma S, Qian M, Lip G. Machine Learning Predicting Atrial Fibrillation as an Adverse Event in the Warfarin and Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial. The American Journal of Medicine 2023;136(11):1099 View
  4. Gue Y, Correa E, Thompson J, Homma S, Qian M, Lip G. MACHINE LEARNING PREDICTING ATRIAL FIBRILLATION AS AN ADVERSE EVENT IN THE WARFARIN VERSUS ASPIRIN IN REDUCED CARDIAC EJECTION FRACTION (WARCEF) TRIAL (Preprint). JMIR AI 2022 View